Department of Mechanical Engineering, University of Connecticut, Storrs, CT 06269, USA.
Phys Chem Chem Phys. 2018 Jun 20;20(24):16372-16385. doi: 10.1039/c7cp08644j.
For nanoparticle (NP)-based drug delivery platforms, the elasticity of the NPs has a significant influence on their blood circulation time and cellular uptake efficiency. However, due to the complexity of the endocytosis process and the inconsistency in the definition of elasticity for NPs in experiments, the understanding about the receptor-mediated endocytosis process of elastic NPs is still limited. In this work, we developed a coarse-grained molecular dynamics (CGMD) model for elastic NPs. The energy change of the elastic NPs can be precisely controlled by the bond, area, volume and bending potentials of this CGMD model. To represent liposomes with different elasticities, we systematically varied the bending rigidity of elastic NPs in CGMD simulations. Additionally, we changed the radius of the elastic NPs to explore the potential size effect. Through virtual nano-indentation tests, we found that the effective stiffness of elastic NPs was determined by their bending rigidity and size. Afterwards, we investigated the receptor-mediated endocytosis process of elastic NPs with different sizes and bending rigidities. We found that the membrane wrapping of soft NPs was faster than that of the stiff ones at the early stage, due to the NP deformation induced large contact area between the NPs and the membrane. However, because of the large energy penalties induced by the NP deformation, the membrane wrapping speed of soft NPs slows down during the late stage. Eventually, the soft NPs are wrapped less efficiently than the stiff ones during the membrane wrapping process. Through systematic CGMD simulations, we found a scaling law between the cellular uptake efficiency and the phenomenal bending rigidity of elastic NPs, which agrees reasonably well with experimental observations. Furthermore, we observed that the membrane wrapping efficiencies of soft and stiff NPs with large sizes were close to each other, due to the stronger ligand-receptor binding force and smaller difference in the stiffness of elastic NPs. Our computational model provides an effective tool to investigate the receptor-mediated endocytosis of elastic NPs with well controlled mechanical properties. This study can also be applied to guide the design of NP-based drug carriers with high efficacy, by utilizing their elastic properties.
对于基于纳米颗粒 (NP) 的药物递送平台,NP 的弹性对其血液循环时间和细胞摄取效率有重大影响。然而,由于内吞过程的复杂性以及实验中 NP 弹性的定义不一致,对于弹性 NP 的受体介导内吞过程的理解仍然有限。在这项工作中,我们开发了一种用于弹性 NP 的粗粒化分子动力学 (CGMD) 模型。该 CGMD 模型的键、面积、体积和弯曲势可以精确控制弹性 NP 的能量变化。为了表示具有不同弹性的脂质体,我们在 CGMD 模拟中系统地改变了弹性 NP 的弯曲刚度。此外,我们改变了弹性 NP 的半径以探索潜在的尺寸效应。通过虚拟纳米压痕测试,我们发现弹性 NP 的有效刚度取决于其弯曲刚度和尺寸。随后,我们研究了具有不同尺寸和弯曲刚度的弹性 NP 的受体介导内吞过程。我们发现,由于 NP 变形导致 NP 与膜之间的接触面积增大,软 NP 的膜包裹速度在早期比硬 NP 快。然而,由于 NP 变形引起的大能量罚值,软 NP 的膜包裹速度在后期会减慢。最终,在膜包裹过程中,软 NP 的包裹效率不如硬 NP。通过系统的 CGMD 模拟,我们发现了细胞摄取效率与弹性 NP 的表观弯曲刚度之间的标度律,该规律与实验观察结果相当吻合。此外,我们观察到具有较大尺寸的软 NP 和硬 NP 的膜包裹效率彼此接近,这是由于配体-受体结合力较强以及弹性 NP 之间的刚度差异较小所致。我们的计算模型为研究具有良好控制机械性能的弹性 NP 的受体介导内吞提供了有效的工具。该研究还可以通过利用 NP 的弹性来指导设计高效的基于 NP 的药物载体。